Reassessment of the care of the patient with chronic kidney disease.
The paper by Fischer et al. focuses attention on the striking prevalence of depressive symptoms in non-dialyzed chronic kidney disease patients. The presence of depressive symptoms correlated with various health-related quality of life measures and economic status. These findings suggest that our view of providing care needs to broaden to incorporate not only thorough medical care, education, and dietary support, but also psychosocial assessments. They also underscore the importance of providing this care to those who are most vulnerable.
Finkelstein
Fredric O
FO
Hospital of St Raphael, New Haven, Connecticut, USA. fof@comcast.net
Finkelstein
Susan H
SH
D001741:Black or African American / Q000523:psychology; D000928:Antidepressive Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D015897:Comorbidity; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy* / Q000208:ethnology; D004651:Employment; D005919:Glomerular Filtration Rate; D054625:Healthcare Disparities; D006801:Humans; D007182:Income; D007668:Kidney / Q000503:physiopathology; D007674:Kidney Diseases / Q000208:ethnology / Q000523:psychology / Q000628:therapy*; D010549:Personal Satisfaction; D015995:Prevalence; D011787:Quality of Health Care; D011788:Quality of Life; D018570:Risk Assessment; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D000928:Antidepressive Agents